Breast cancer?is a disease in which cells in the breast grow out of control. There are different kinds of?breast cancer.?
This report contains market size and forecasts of Targeted Therapy for Breast Cancer in Global, including the following market information:
Global Targeted Therapy for Breast Cancer Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global top five companies in 2022 (%)
The global Targeted Therapy for Breast Cancer market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Brand Drugs Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Targeted Therapy for Breast Cancer include Eli Lilly and Company, Roche, Merck & Co., Novartis, Pfizer, Merck KGaA, Astellas, Janssen Biotech and Bristol-Myers Squibb, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Targeted Therapy for Breast Cancer companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Targeted Therapy for Breast Cancer Market, by Type, 2018-2023, 2023-2030 ($ millions)
Global Targeted Therapy for Breast Cancer Market Segment Percentages, by Type, 2022 (%)
Brand Drugs
Generic Drug
Global Targeted Therapy for Breast Cancer Market, by Application, 2018-2023, 2023-2030 ($ millions)
Global Targeted Therapy for Breast Cancer Market Segment Percentages, by Application, 2022 (%)
Hospital
Retail Pharmacy
Other
Global Targeted Therapy for Breast Cancer Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions)
Global Targeted Therapy for Breast Cancer Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Targeted Therapy for Breast Cancer revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Targeted Therapy for Breast Cancer revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Eli Lilly and Company
Roche
Merck & Co.
Novartis
Pfizer
Merck KGaA
Astellas
Janssen Biotech
Bristol-Myers Squibb
Gilead Sciences
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Targeted Therapy for Breast Cancer Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Targeted Therapy for Breast Cancer Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Targeted Therapy for Breast Cancer Overall Market Size
2.1 Global Targeted Therapy for Breast Cancer Market Size: 2022 VS 2030
2.2 Global Targeted Therapy for Breast Cancer Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Targeted Therapy for Breast Cancer Players in Global Market
3.2 Top Global Targeted Therapy for Breast Cancer Companies Ranked by Revenue
3.3 Global Targeted Therapy for Breast Cancer Revenue by Companies
3.4 Top 3 and Top 5 Targeted Therapy for Breast Cancer Companies in Global Market, by Revenue in 2022
3.5 Global Companies Targeted Therapy for Breast Cancer Product Type
3.6 Tier 1, Tier 2 and Tier 3 Targeted Therapy for Breast Cancer Players in Global Market
3.6.1 List of Global Tier 1 Targeted Therapy for Breast Cancer Companies
3.6.2 List of Global Tier 2 and Tier 3 Targeted Therapy for Breast Cancer Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Targeted Therapy for Breast Cancer Market Size Markets, 2022 & 2030
4.1.2 Brand Drugs
4.1.3 Generic Drug
4.2 By Type - Global Targeted Therapy for Breast Cancer Revenue & Forecasts
4.2.1 By Type - Global Targeted Therapy for Breast Cancer Revenue, 2018-2023
4.2.2 By Type - Global Targeted Therapy for Breast Cancer Revenue, 2023-2030
4.2.3 By Type - Global Targeted Therapy for Breast Cancer Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Targeted Therapy for Breast Cancer Market Size, 2022 & 2030
5.1.2 Hospital
5.1.3 Retail Pharmacy
5.1.4 Other
5.2 By Application - Global Targeted Therapy for Breast Cancer Revenue & Forecasts
5.2.1 By Application - Global Targeted Therapy for Breast Cancer Revenue, 2018-2023
5.2.2 By Application - Global Targeted Therapy for Breast Cancer Revenue, 2023-2030
5.2.3 By Application - Global Targeted Therapy for Breast Cancer Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Targeted Therapy for Breast Cancer Market Size, 2022 & 2030
6.2 By Region - Global Targeted Therapy for Breast Cancer Revenue & Forecasts
6.2.1 By Region - Global Targeted Therapy for Breast Cancer Revenue, 2018-2023
6.2.2 By Region - Global Targeted Therapy for Breast Cancer Revenue, 2023-2030
6.2.3 By Region - Global Targeted Therapy for Breast Cancer Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Targeted Therapy for Breast Cancer Revenue, 2018-2030
6.3.2 US Targeted Therapy for Breast Cancer Market Size, 2018-2030
6.3.3 Canada Targeted Therapy for Breast Cancer Market Size, 2018-2030
6.3.4 Mexico Targeted Therapy for Breast Cancer Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Targeted Therapy for Breast Cancer Revenue, 2018-2030
6.4.2 Germany Targeted Therapy for Breast Cancer Market Size, 2018-2030
6.4.3 France Targeted Therapy for Breast Cancer Market Size, 2018-2030
6.4.4 U.K. Targeted Therapy for Breast Cancer Market Size, 2018-2030
6.4.5 Italy Targeted Therapy for Breast Cancer Market Size, 2018-2030
6.4.6 Russia Targeted Therapy for Breast Cancer Market Size, 2018-2030
6.4.7 Nordic Countries Targeted Therapy for Breast Cancer Market Size, 2018-2030
6.4.8 Benelux Targeted Therapy for Breast Cancer Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Targeted Therapy for Breast Cancer Revenue, 2018-2030
6.5.2 China Targeted Therapy for Breast Cancer Market Size, 2018-2030
6.5.3 Japan Targeted Therapy for Breast Cancer Market Size, 2018-2030
6.5.4 South Korea Targeted Therapy for Breast Cancer Market Size, 2018-2030
6.5.5 Southeast Asia Targeted Therapy for Breast Cancer Market Size, 2018-2030
6.5.6 India Targeted Therapy for Breast Cancer Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Targeted Therapy for Breast Cancer Revenue, 2018-2030
6.6.2 Brazil Targeted Therapy for Breast Cancer Market Size, 2018-2030
6.6.3 Argentina Targeted Therapy for Breast Cancer Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Targeted Therapy for Breast Cancer Revenue, 2018-2030
6.7.2 Turkey Targeted Therapy for Breast Cancer Market Size, 2018-2030
6.7.3 Israel Targeted Therapy for Breast Cancer Market Size, 2018-2030
6.7.4 Saudi Arabia Targeted Therapy for Breast Cancer Market Size, 2018-2030
6.7.5 UAE Targeted Therapy for Breast Cancer Market Size, 2018-2030
7 Players Profiles
7.1 Eli Lilly and Company
7.1.1 Eli Lilly and Company Corporate Summary
7.1.2 Eli Lilly and Company Business Overview
7.1.3 Eli Lilly and Company Targeted Therapy for Breast Cancer Major Product Offerings
7.1.4 Eli Lilly and Company Targeted Therapy for Breast Cancer Revenue in Global Market (2018-2023)
7.1.5 Eli Lilly and Company Key News
7.2 Roche
7.2.1 Roche Corporate Summary
7.2.2 Roche Business Overview
7.2.3 Roche Targeted Therapy for Breast Cancer Major Product Offerings
7.2.4 Roche Targeted Therapy for Breast Cancer Revenue in Global Market (2018-2023)
7.2.5 Roche Key News
7.3 Merck & Co.
7.3.1 Merck & Co. Corporate Summary
7.3.2 Merck & Co. Business Overview
7.3.3 Merck & Co. Targeted Therapy for Breast Cancer Major Product Offerings
7.3.4 Merck & Co. Targeted Therapy for Breast Cancer Revenue in Global Market (2018-2023)
7.3.5 Merck & Co. Key News
7.4 Novartis
7.4.1 Novartis Corporate Summary
7.4.2 Novartis Business Overview
7.4.3 Novartis Targeted Therapy for Breast Cancer Major Product Offerings
7.4.4 Novartis Targeted Therapy for Breast Cancer Revenue in Global Market (2018-2023)
7.4.5 Novartis Key News
7.5 Pfizer
7.5.1 Pfizer Corporate Summary
7.5.2 Pfizer Business Overview
7.5.3 Pfizer Targeted Therapy for Breast Cancer Major Product Offerings
7.5.4 Pfizer Targeted Therapy for Breast Cancer Revenue in Global Market (2018-2023)
7.5.5 Pfizer Key News
7.6 Merck KGaA
7.6.1 Merck KGaA Corporate Summary
7.6.2 Merck KGaA Business Overview
7.6.3 Merck KGaA Targeted Therapy for Breast Cancer Major Product Offerings
7.6.4 Merck KGaA Targeted Therapy for Breast Cancer Revenue in Global Market (2018-2023)
7.6.5 Merck KGaA Key News
7.7 Astellas
7.7.1 Astellas Corporate Summary
7.7.2 Astellas Business Overview
7.7.3 Astellas Targeted Therapy for Breast Cancer Major Product Offerings
7.7.4 Astellas Targeted Therapy for Breast Cancer Revenue in Global Market (2018-2023)
7.7.5 Astellas Key News
7.8 Janssen Biotech
7.8.1 Janssen Biotech Corporate Summary
7.8.2 Janssen Biotech Business Overview
7.8.3 Janssen Biotech Targeted Therapy for Breast Cancer Major Product Offerings
7.8.4 Janssen Biotech Targeted Therapy for Breast Cancer Revenue in Global Market (2018-2023)
7.8.5 Janssen Biotech Key News
7.9 Bristol-Myers Squibb
7.9.1 Bristol-Myers Squibb Corporate Summary
7.9.2 Bristol-Myers Squibb Business Overview
7.9.3 Bristol-Myers Squibb Targeted Therapy for Breast Cancer Major Product Offerings
7.9.4 Bristol-Myers Squibb Targeted Therapy for Breast Cancer Revenue in Global Market (2018-2023)
7.9.5 Bristol-Myers Squibb Key News
7.10 Gilead Sciences
7.10.1 Gilead Sciences Corporate Summary
7.10.2 Gilead Sciences Business Overview
7.10.3 Gilead Sciences Targeted Therapy for Breast Cancer Major Product Offerings
7.10.4 Gilead Sciences Targeted Therapy for Breast Cancer Revenue in Global Market (2018-2023)
7.10.5 Gilead Sciences Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Targeted Therapy for Breast Cancer Market Opportunities & Trends in Global Market
Table 2. Targeted Therapy for Breast Cancer Market Drivers in Global Market
Table 3. Targeted Therapy for Breast Cancer Market Restraints in Global Market
Table 4. Key Players of Targeted Therapy for Breast Cancer in Global Market
Table 5. Top Targeted Therapy for Breast Cancer Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Targeted Therapy for Breast Cancer Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Targeted Therapy for Breast Cancer Revenue Share by Companies, 2018-2023
Table 8. Global Companies Targeted Therapy for Breast Cancer Product Type
Table 9. List of Global Tier 1 Targeted Therapy for Breast Cancer Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Targeted Therapy for Breast Cancer Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Targeted Therapy for Breast Cancer Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Targeted Therapy for Breast Cancer Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Targeted Therapy for Breast Cancer Revenue in Global (US$, Mn), 2023-2030
Table 14. By Application ? Global Targeted Therapy for Breast Cancer Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Targeted Therapy for Breast Cancer Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Targeted Therapy for Breast Cancer Revenue in Global (US$, Mn), 2023-2030
Table 17. By Region ? Global Targeted Therapy for Breast Cancer Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Targeted Therapy for Breast Cancer Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Targeted Therapy for Breast Cancer Revenue (US$, Mn), 2023-2030
Table 20. By Country - North America Targeted Therapy for Breast Cancer Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Targeted Therapy for Breast Cancer Revenue, (US$, Mn), 2023-2030
Table 22. By Country - Europe Targeted Therapy for Breast Cancer Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Targeted Therapy for Breast Cancer Revenue, (US$, Mn), 2023-2030
Table 24. By Region - Asia Targeted Therapy for Breast Cancer Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Targeted Therapy for Breast Cancer Revenue, (US$, Mn), 2023-2030
Table 26. By Country - South America Targeted Therapy for Breast Cancer Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Targeted Therapy for Breast Cancer Revenue, (US$, Mn), 2023-2030
Table 28. By Country - Middle East & Africa Targeted Therapy for Breast Cancer Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Targeted Therapy for Breast Cancer Revenue, (US$, Mn), 2023-2030
Table 30. Eli Lilly and Company Corporate Summary
Table 31. Eli Lilly and Company Targeted Therapy for Breast Cancer Product Offerings
Table 32. Eli Lilly and Company Targeted Therapy for Breast Cancer Revenue (US$, Mn), (2018-2023)
Table 33. Roche Corporate Summary
Table 34. Roche Targeted Therapy for Breast Cancer Product Offerings
Table 35. Roche Targeted Therapy for Breast Cancer Revenue (US$, Mn), (2018-2023)
Table 36. Merck & Co. Corporate Summary
Table 37. Merck & Co. Targeted Therapy for Breast Cancer Product Offerings
Table 38. Merck & Co. Targeted Therapy for Breast Cancer Revenue (US$, Mn), (2018-2023)
Table 39. Novartis Corporate Summary
Table 40. Novartis Targeted Therapy for Breast Cancer Product Offerings
Table 41. Novartis Targeted Therapy for Breast Cancer Revenue (US$, Mn), (2018-2023)
Table 42. Pfizer Corporate Summary
Table 43. Pfizer Targeted Therapy for Breast Cancer Product Offerings
Table 44. Pfizer Targeted Therapy for Breast Cancer Revenue (US$, Mn), (2018-2023)
Table 45. Merck KGaA Corporate Summary
Table 46. Merck KGaA Targeted Therapy for Breast Cancer Product Offerings
Table 47. Merck KGaA Targeted Therapy for Breast Cancer Revenue (US$, Mn), (2018-2023)
Table 48. Astellas Corporate Summary
Table 49. Astellas Targeted Therapy for Breast Cancer Product Offerings
Table 50. Astellas Targeted Therapy for Breast Cancer Revenue (US$, Mn), (2018-2023)
Table 51. Janssen Biotech Corporate Summary
Table 52. Janssen Biotech Targeted Therapy for Breast Cancer Product Offerings
Table 53. Janssen Biotech Targeted Therapy for Breast Cancer Revenue (US$, Mn), (2018-2023)
Table 54. Bristol-Myers Squibb Corporate Summary
Table 55. Bristol-Myers Squibb Targeted Therapy for Breast Cancer Product Offerings
Table 56. Bristol-Myers Squibb Targeted Therapy for Breast Cancer Revenue (US$, Mn), (2018-2023)
Table 57. Gilead Sciences Corporate Summary
Table 58. Gilead Sciences Targeted Therapy for Breast Cancer Product Offerings
Table 59. Gilead Sciences Targeted Therapy for Breast Cancer Revenue (US$, Mn), (2018-2023)
List of Figures
Figure 1. Targeted Therapy for Breast Cancer Segment by Type in 2022
Figure 2. Targeted Therapy for Breast Cancer Segment by Application in 2022
Figure 3. Global Targeted Therapy for Breast Cancer Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Targeted Therapy for Breast Cancer Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Targeted Therapy for Breast Cancer Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Targeted Therapy for Breast Cancer Revenue in 2022
Figure 8. By Type - Global Targeted Therapy for Breast Cancer Revenue Market Share, 2018-2030
Figure 9. By Application - Global Targeted Therapy for Breast Cancer Revenue Market Share, 2018-2030
Figure 10. By Region - Global Targeted Therapy for Breast Cancer Revenue Market Share, 2018-2030
Figure 11. By Country - North America Targeted Therapy for Breast Cancer Revenue Market Share, 2018-2030
Figure 12. US Targeted Therapy for Breast Cancer Revenue, (US$, Mn), 2018-2030
Figure 13. Canada Targeted Therapy for Breast Cancer Revenue, (US$, Mn), 2018-2030
Figure 14. Mexico Targeted Therapy for Breast Cancer Revenue, (US$, Mn), 2018-2030
Figure 15. By Country - Europe Targeted Therapy for Breast Cancer Revenue Market Share, 2018-2030
Figure 16. Germany Targeted Therapy for Breast Cancer Revenue, (US$, Mn), 2018-2030
Figure 17. France Targeted Therapy for Breast Cancer Revenue, (US$, Mn), 2018-2030
Figure 18. U.K. Targeted Therapy for Breast Cancer Revenue, (US$, Mn), 2018-2030
Figure 19. Italy Targeted Therapy for Breast Cancer Revenue, (US$, Mn), 2018-2030
Figure 20. Russia Targeted Therapy for Breast Cancer Revenue, (US$, Mn), 2018-2030
Figure 21. Nordic Countries Targeted Therapy for Breast Cancer Revenue, (US$, Mn), 2018-2030
Figure 22. Benelux Targeted Therapy for Breast Cancer Revenue, (US$, Mn), 2018-2030
Figure 23. By Region - Asia Targeted Therapy for Breast Cancer Revenue Market Share, 2018-2030
Figure 24. China Targeted Therapy for Breast Cancer Revenue, (US$, Mn), 2018-2030
Figure 25. Japan Targeted Therapy for Breast Cancer Revenue, (US$, Mn), 2018-2030
Figure 26. South Korea Targeted Therapy for Breast Cancer Revenue, (US$, Mn), 2018-2030
Figure 27. Southeast Asia Targeted Therapy for Breast Cancer Revenue, (US$, Mn), 2018-2030
Figure 28. India Targeted Therapy for Breast Cancer Revenue, (US$, Mn), 2018-2030
Figure 29. By Country - South America Targeted Therapy for Breast Cancer Revenue Market Share, 2018-2030
Figure 30. Brazil Targeted Therapy for Breast Cancer Revenue, (US$, Mn), 2018-2030
Figure 31. Argentina Targeted Therapy for Breast Cancer Revenue, (US$, Mn), 2018-2030
Figure 32. By Country - Middle East & Africa Targeted Therapy for Breast Cancer Revenue Market Share, 2018-2030
Figure 33. Turkey Targeted Therapy for Breast Cancer Revenue, (US$, Mn), 2018-2030
Figure 34. Israel Targeted Therapy for Breast Cancer Revenue, (US$, Mn), 2018-2030
Figure 35. Saudi Arabia Targeted Therapy for Breast Cancer Revenue, (US$, Mn), 2018-2030
Figure 36. UAE Targeted Therapy for Breast Cancer Revenue, (US$, Mn), 2018-2030
Figure 37. Eli Lilly and Company Targeted Therapy for Breast Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 38. Roche Targeted Therapy for Breast Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 39. Merck & Co. Targeted Therapy for Breast Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 40. Novartis Targeted Therapy for Breast Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 41. Pfizer Targeted Therapy for Breast Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Merck KGaA Targeted Therapy for Breast Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Astellas Targeted Therapy for Breast Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Janssen Biotech Targeted Therapy for Breast Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Bristol-Myers Squibb Targeted Therapy for Breast Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Gilead Sciences Targeted Therapy for Breast Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
